|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Ranibizumab (Lucentis®) (mAb-based) ELISA | C3a Des Arg RIA Assay | Chromogranin A ELISA Assay | Cyfra ELISA Assay | Gd-IgA1 (Galactose-deficient IgA1) ELISA |
| Catalog Number | TM09034 | RK-518 | CGA RUO | 211-10 | 27600 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Enzyme immunoassay for the specific determination of free Ranibizumab in aqueous humour. For research use only - not for use in diagnostic procedures. Not for use in serum or plasma. | Radioimmunoassay (RIA) for the determination of human Complement C3a des Arg in human plasma. For research use only, not for use in diagnostic procedures. | Enzyme-linked immunosorbent assay (ELISA) for the determination of Chromogranin A in human plasma or serum. For research use only, not for use in diagnostic procedures. | Solid phase, non-competitive immunoassay (ELISA) for the determination of soluble cytokeratin 19 fragments in human serum. 510(k) cleared, can be used in diagnostic procedures. | Solid phase sandwich ELISA for the determination of Gd-IgA1 (Galactose-deficient IgA1) in human serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures.
Galactose-deficient IgA1 (Gd-IgA1) has attracted a lot of attention as a critical effector molecule in the Solid phase sandwich ELISA for the determination of Gd-IgA1 (Galactose-deficient IgA1) in human serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures.
Galactose-deficient IgA1 (Gd-IgA1) has attracted a lot of attention as a critical effector molecule in the pathogenesis and progression of IgA nephropathy (IgAN) in recent studies. It has been suggested that several O-link glycans-modified regions exist in the heavy chain hinge region of human IgA1 molecule and Gd-IgA1 circulates in the bloodstream of test samples with the pathological condition of IgAN.... Read More |
| Detection Target | Normetanephrine | Insulin | Complement System MBL Pathway | Adrenaline / Noradrenaline / Dopamine | Metanephrine / Normetanephrine |
| Sample Type | Urine | Serum | Serum | Multiple | Urine |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Radio Immuno Assay (RIA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | 0 / 10 - 300 ng/mL | 20 to 500 ng/mL | 36 to 1800 ng/mL | 1.4 to 47.6 ng/mL | 1.56 to 100.0 ng/mL |
| Sensitivity | 23 ng/mL | 1 µIU/mL | Inquire | Adrenaline: 0.25 ng/mL x C*; Noradrenaline: 0.1 ng/mL x C*; Dopamine 0.25 ng/mL x C*. Sensitivity based on calculated correction factor. | Metanephrine: 13 ng/mL; Normetanephrine: 23 ng/mL. |
| Assay Time | 2 hour, 15 min. total incubation time. | 1 hr, 30 mins (incubation) | 1 hr 45 mins (incubation) | 1 hr 45 mins (incubation) | 2 hours (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |